Outcomes and prognostic factors in thyroid cancer patients with cranial metastases: A retrospective cohort study of 4,683 patients

被引:12
|
作者
Hong, Yi-Wen [1 ]
Lin, Jen-Der [2 ]
Yu, Ming-Chin [1 ]
Hsu, Chih-Chieh [1 ]
Lin, Yann-Sheng [1 ]
机构
[1] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Branch, Dept Surg, 5 Fuxing St, Taoyuan 333, Taiwan
[2] Chang Gung Univ, Chang Gung Mem Hosp, Linkou Branch, Div Endocrinol & Metab,Dept Internal Med, 5 Fuxing St, Taoyuan 333, Taiwan
关键词
Thyroid cancer; Brain metastasis; Skull metastasis; Radioiodine; Surgery; BRAIN METASTASES; FOLLOW-UP; DISTANT METASTASIS; SKULL METASTASIS; CARCINOMA; PAPILLARY; RADIOIODINE; MANAGEMENT;
D O I
10.1016/j.ijsu.2018.06.001
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Cranial metastasis of thyroid cancer is rare. The aim of this study was to analyse the clinical characteristics, treatments and outcomes of thyroid cancer patients with cranial metastasis and to identify the associated prognostic factors. Materials and methods: Between January 1977 and August 2017, a total of 4683 patients were histologically confirmed to have thyroid cancer. Among them, 25 patients (0.53%) were identified as having cranial metastases, and their medical records were reviewed. The Kaplan-Meier method with a log-rank test was performed with cancer-specific survival as the main outcome. Cox regression analysis was used to examine the potential prognostic factors influencing patient survival. Results: Of the 25 patients, 21 were female, and 4 were male. The median age at the time of diagnosis of cranial metastasis was 63 years. Sixteen patients had metastases to the brain, and nine patients had metastases involving the skull only. Papillary carcinoma and follicular carcinoma accounted for 84.0% of cases. Twenty-four cases (96.0%) had extracranial metastases at the time of diagnosis of cranial metastases. Twenty patients received surgery, and 4 patients received palliative radiotherapy. One patient received supportive care only. The median cancer-specific survival after the diagnosis of cranial metastases was 27 months. According to the Kaplan-Meier test, 3 factors had a significant impact on survival, the metastatic site, histological types and surgical resection. According to the Cox regression analysis, skull metastases (HR: 0.274, 95% CI: 0.083-0.904, p = 0.033) and surgical resection (HR: 0.134, 95% CI: 0.019-0.929, p = 0.042) were identified as independent prognostic factors for a better outcome. Conclusions: Surgical resection is the mainstay therapy for thyroid cancer patients with cranial metastasis. Cranial metastases involving the skull only are associated with a better outcome.
引用
收藏
页码:182 / 187
页数:6
相关论文
共 50 条
  • [31] Prognostic factors of renal cell cancer in elderly patients: a population-based cohort study
    Pajunen, Heini
    Veitonmaki, Thea
    Huhtala, Heini
    Nikkola, Jussi
    Poyhonen, Antti
    Murtola, Teemu
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [32] The risk and prognostic factors for liver metastases in esophageal cancer patients: A large-cohort based study
    Luo, Peng
    Wei, Xiufeng
    Liu, Chen
    Chen, Xiankai
    Yang, Yafan
    Zhang, Ruixiang
    Kang, Xiaozheng
    Qin, Jianjun
    Qi, Xiuzhu
    Li, Yin
    THORACIC CANCER, 2022, 13 (21) : 2960 - 2969
  • [33] Long-term outcomes and prognostic factors in papillary thyroid microcarcinoma patients with distant metastases
    Weng, Huai-Yu
    Yan, Ting
    Qiu, Wang-Wang
    Xi, Chuang
    Hou, Li-Ying
    Yang, Zhi-Li
    Qiu, Zhong-Ling
    ENDOCRINE, 2022, 75 (02) : 495 - 507
  • [34] LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA AND BONE METASTASES
    Slook, Omer
    Levy, Sigal
    Slutzky-Shraga, Ilana
    Tsvetov, Gloria
    Robenshtok, Eyal
    Shimon, Ilan
    Benbassat, Carlos
    Hirsch, Dania
    ENDOCRINE PRACTICE, 2019, 25 (05) : 427 - 437
  • [35] Brain Metastases of Non-Small Cell Lung Cancer: Prognostic Factors in Patients with Surgical Resection
    Ramos Antuna, Aida
    Alvarez Vega, Marco
    Rodriguez Sanchez, Carmen
    Martin Fernandez, Vanesa
    JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY, 2018, 79 (02) : 101 - 107
  • [36] An Institutional Retrospective Analysis of 93 Patients with Brain Metastases from Breast Cancer: Treatment Outcomes, Diagnosis-Specific Prognostic Factors
    Antoni, Delphine
    Clavier, Jean-Baptiste
    Pop, Marius
    Benoit, Celine
    Lefebvre, Francois
    Noel, Georges
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (12) : 16489 - 16499
  • [37] Prognostic significance of osteopenia in patients with colorectal cancer: A retrospective cohort study
    Kamada, Teppei
    Furukawa, Kenei
    Takahashi, Junji
    Nakashima, Keigo
    Nakaseko, Yuichi
    Suzuki, Norihiko
    Yoshida, Masashi
    Ohdaira, Hironori
    Ikegami, Toru
    Suzuki, Yutaka
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2021, 5 (06): : 832 - 843
  • [38] Prognostic factors and the effect of radioiodine on patients with locally advanced differentiated thyroid cancer
    Yao, Yao
    Cheng, Shuai
    Xu, Xinyu
    Chen, Xinyuan
    Chen, Wei
    Qian, Yichun
    Zhang, Yuan
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (15)
  • [39] Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis
    Naoki Niikura
    Naoki Hayashi
    Norikazu Masuda
    Seiki Takashima
    Rikiya Nakamura
    Ken-ichi Watanabe
    Chizuko Kanbayashi
    Mayumi Ishida
    Yasuo Hozumi
    Michiko Tsuneizumi
    Naoto Kondo
    Yoichi Naito
    Yayoi Honda
    Akira Matsui
    Tomomi Fujisawa
    Risa Oshitanai
    Hiroyuki Yasojima
    Yutaka Tokuda
    Shigehira Saji
    Hiroji Iwata
    Breast Cancer Research and Treatment, 2014, 147 : 103 - 112
  • [40] Treatment outcomes and prognostic factors for patients with brain metastases from breast cancer of each subtype: a multicenter retrospective analysis
    Niikura, Naoki
    Hayashi, Naoki
    Masuda, Norikazu
    Takashima, Seiki
    Nakamura, Rikiya
    Watanabe, Ken-ichi
    Kanbayashi, Chizuko
    Ishida, Mayumi
    Hozumi, Yasuo
    Tsuneizumi, Michiko
    Kondo, Naoto
    Naito, Yoichi
    Honda, Yayoi
    Matsui, Akira
    Fujisawa, Tomomi
    Oshitanai, Risa
    Yasojima, Hiroyuki
    Tokuda, Yutaka
    Saji, Shigehira
    Iwata, Hiroji
    BREAST CANCER RESEARCH AND TREATMENT, 2014, 147 (01) : 103 - 112